Answers are grounded in this paper and cite their sources.
Retrospective cohort study reveals the serum creatinine/albumin ratio predicts 28-day mortality in heart failure, indicating its utility for early risk stratification.
Background: Heart failure (HF) is a global health challenge with high morbidity and mortality. The serum creatinine/albumin ratio (CAR), a marker of renal dysfunction and malnutrition, has shown prognostic value in other critical illnesses but remains underexplored in HF patients. Methods: This retrospective cohort study included 1,893 HF patients hospitalized at the Fourth People's Hospital of Zigong, China, between December 2016 and June 2019. Cox proportional hazards models assessed the association between CAR and 28-day mortality. Dose-response relationship was assessed using restricted cubic spline analysis, Kaplan-Meier curves illustrated survival differences, and Receiver Operating Characteristic (ROC) analysis evaluated CAR's predictive performance. ROC analysis showed that CAR had an AUC of 77.1%, which was slightly higher than creatinine alone (76.2%) and markedly better than BNP (68.0%) and albumin alone (64.9%). Conclusion: In patients with HF, CAR may serve as an independent predictor of 28-day mortality. Its ability to simultaneously reflect renal dysfunction, malnutrition, and inflammation highlights its potential as a valuable biomarker for risk stratification. Further multicenter, prospective studies are needed to confirm its clinical utility and investigate its role alongside other biomarkers in guiding personalized treatment strategies and improving patient outcomes.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: